Type-1 diabetes accounts for 5%–10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes. 
This report contains market size and forecasts of Type-1 Diabetes Treatment in Global, including the following market information:
Global Type-1 Diabetes Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Type-1 Diabetes Treatment market was valued at 5165.4 million in 2021 and is projected to reach US$ 6938.7 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rapid-Acting Insulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Type-1 Diabetes Treatment include Astellas Pharma, Merck, Eli Lilly, Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim GmbH, Novartis and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Type-1 Diabetes Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Type-1 Diabetes Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Type-1 Diabetes Treatment Market Segment Percentages, by Type, 2021 (%)
Rapid-Acting Insulin
Short-Acting Insulin
Others
Global Type-1 Diabetes Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Type-1 Diabetes Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals & Clinics
Academic & Research Institutes
Global Type-1 Diabetes Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Type-1 Diabetes Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Type-1 Diabetes Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Type-1 Diabetes Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma
Merck
Eli Lilly
Novo Nordisk
Sanofi
AstraZeneca
Boehringer Ingelheim GmbH
Novartis
Pfizer Inc.
Abbott Laboratories
Mannkind Corporation
Braun Melsungen AG
Macrogenics, Inc.